Taking a swipe at Donald Trump without taking the US Presidents name, Microsoft co-founder Bill Gates described the Joe Biden and Kamala Harris team as a "very good set of people" without "outliers" who contradict public health experts during a raging pandemic.
"I think the Biden team of people is a very good set of people who have track records of scientists working on healthcare... you don't have any, you know, outliers in terms of not believing in public health, so it looks good to me," Gates said in a late night television interview.
Gates welcomed the recent 90 per cent efficacy results from Pfizer and Moderna. He is betting on AstraZeneca getting UK approval "not too long from now" and expects Novavax and Johnson and Johnson approvals to "come fairly early next year."
"And these vaccines are easier to scale up to get global coverage. So, the vaccine front is looking very promising", Gates told CNN, referring to the world of non-Pfizer and non-Moderna class of vaccines, where the cold chain requirements are less daunting.
(Nikhila Natarajan can be reached at nikhilanatarajan@gmail.com)
--IANS
nikhila/sdr/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)